Time of Cannulation During Primary ERCP With Short Guide Wire Rapid Exchange or With Long Guide Wire

NCT ID: NCT02290769

Last Updated: 2023-03-22

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

SUSPENDED

Clinical Phase

NA

Total Enrollment

292 participants

Study Classification

INTERVENTIONAL

Study Start Date

2018-01-28

Study Completion Date

2025-12-14

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The aim of this study is to compare the cannulation time during primary wire guided ERCP (Endoscopic Retrograde Cholangio-Pancreatography) according to two different length of guide wire: long wire or short wire rapid exchange, artery by a prospective randomized trial.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

In primary Endoscopic Retrograde Cholangio-Pancreatography (ERCP) cannulation is wire guided. Up to now there is no doubt about the efficacy of such a procedure. The use of long wire requires the help of another person behind primary operator. The use of short wire rapid exchange allows the primary operator to perform all the steps by himself. Time of cannulation is known to be directly associated to post ERCP pancreatitis.

Aim of the study is to assess which length of guide wire allows the shorter cannulation time during primary ERCP. Post ERCP pancreatitis onset will be assessed for all patients

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Pancreatitis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Short guide wire rapid exchange

Use of short guide wire rapid exchange to guide the cannulation during primary ERCP

Group Type EXPERIMENTAL

Short guide wire rapid exchange

Intervention Type DEVICE

Use of short guide wire rapid exchange to guide the cannulation during primary ERCP

Long guide wire

Use of long wire to guide the cannulation during primary ERCP

Group Type ACTIVE_COMPARATOR

Long guide wire

Intervention Type DEVICE

Use of long wire to guide the cannulation during primary ERCP

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Short guide wire rapid exchange

Use of short guide wire rapid exchange to guide the cannulation during primary ERCP

Intervention Type DEVICE

Long guide wire

Use of long wire to guide the cannulation during primary ERCP

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* indication to primary ERCP
* ASA (American Society of Anesthesiologists) 1, 2, 3

Exclusion Criteria

* pancreas neoplasia
* pancreatitis
* ampulloma
* duodenum stenosis
* under mucous membrane haematoma
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Niguarda Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Francesco Pugliese, MD

Role: STUDY_CHAIR

Niguarda Ca' Granda Hospital

Edoardo Forti, MD

Role: STUDY_CHAIR

Niguarda Ca' Granda Hospital

Raffaele Manta, MD

Role: STUDY_CHAIR

Niguarda Ca' Granda Hospital

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Niguarda Hospital

Milan, , Italy

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Italy

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

382 - 072014

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.